Skip to Content

OLAPARIB 50 mg Logo (Lynparza 50 mg)

Generic Name: olaparib

Pill with imprint OLAPARIB 50 mg Logo is White, Capsule-shape and has been identified as Lynparza 50 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Lynparza is used in the treatment of ovarian cancer; prostate cancer; breast cancer, metastatic; pancreatic cancer and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for OLAPARIB 50 mg Logo

Lynparza 50 mg OLAPARIB 50 mg Logo
Lynparza 50 mg OLAPARIB 50 mg Logo
Lynparza 50 mg OLAPARIB 50 mg Logo

Lynparza

Generic Name
olaparib
Imprint
OLAPARIB 50 mg Logo
Strength
50 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Parp inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC)
00310-0657

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.